These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 27111234

  • 1. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
    Kupz A, Zedler U, Stäber M, Perdomo C, Dorhoi A, Brosch R, Kaufmann SH.
    J Clin Invest; 2016 Jun 01; 126(6):2109-22. PubMed ID: 27111234
    [Abstract] [Full Text] [Related]

  • 2. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
    Majlessi L, Brodin P, Brosch R, Rojas MJ, Khun H, Huerre M, Cole ST, Leclerc C.
    J Immunol; 2005 Mar 15; 174(6):3570-9. PubMed ID: 15749894
    [Abstract] [Full Text] [Related]

  • 3. In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection.
    Clemmensen HS, Dube JY, McIntosh F, Rosenkrands I, Jungersen G, Aagaard C, Andersen P, Behr MA, Mortensen R.
    mBio; 2021 Apr 20; 12(2):. PubMed ID: 33879592
    [Abstract] [Full Text] [Related]

  • 4. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
    Palma C, Schiavoni G, Abalsamo L, Mattei F, Piccaro G, Sanchez M, Fernandez C, Singh M, Gabriele L.
    Eur J Immunol; 2013 Sep 20; 43(9):2386-97. PubMed ID: 23719937
    [Abstract] [Full Text] [Related]

  • 5. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X, Zhang J, Liang J, Zhang Y, Teng X, Yuan X, Fan X.
    PLoS One; 2015 Sep 20; 10(3):e0122560. PubMed ID: 25822536
    [Abstract] [Full Text] [Related]

  • 6. T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients.
    Cardoso FL, Antas PR, Milagres AS, Geluk A, Franken KL, Oliveira EB, Teixeira HC, Nogueira SA, Sarno EN, Klatser P, Ottenhoff TH, Sampaio EP.
    Infect Immun; 2002 Dec 20; 70(12):6707-14. PubMed ID: 12438345
    [Abstract] [Full Text] [Related]

  • 7. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z, Wong KW, Zhao HM, Wen HL, Ji P, Ma H, Wu K, Lu SH, Li F, Li ZM, Shu T, Xu JQ, Lowrie DB, Fan XY.
    Mol Ther; 2017 May 03; 25(5):1222-1233. PubMed ID: 28342639
    [Abstract] [Full Text] [Related]

  • 8. ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.
    Silva-Sánchez A, Meza-Pérez S, Flores-Langarica A, Donis-Maturano L, Estrada-García I, Calderón-Amador J, Hernández-Pando R, Idoyaga J, Steinman RM, Flores-Romo L.
    PLoS One; 2015 May 03; 10(4):e0124828. PubMed ID: 25915045
    [Abstract] [Full Text] [Related]

  • 9. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M, Ottenhoff TH.
    Semin Immunol; 2018 Oct 03; 39():88-101. PubMed ID: 30327124
    [Abstract] [Full Text] [Related]

  • 10. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB, Kim WS, Kim JS, Kim H, Kwon KW, Han SJ, Eum SY, Cho SN, Shin SJ.
    PLoS One; 2015 Oct 03; 10(10):e0141577. PubMed ID: 26509812
    [Abstract] [Full Text] [Related]

  • 11. Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups.
    Coppola M, Villar-Hernández R, van Meijgaarden KE, Latorre I, Muriel Moreno B, Garcia-Garcia E, Franken KLMC, Prat C, Stojanovic Z, De Souza Galvão ML, Millet JP, Sabriá J, Sánchez-Montalva A, Noguera-Julian A, Geluk A, Domínguez J, Ottenhoff THM.
    Front Immunol; 2020 Oct 03; 11():103. PubMed ID: 32117257
    [Abstract] [Full Text] [Related]

  • 12. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
    Maurya SK, Aqdas M, Das DK, Singh S, Nadeem S, Kaur G, Agrewala JN.
    BMC Infect Dis; 2020 Sep 17; 20(1):677. PubMed ID: 32942991
    [Abstract] [Full Text] [Related]

  • 13. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
    Choi HG, Choi S, Back YW, Paik S, Park HS, Kim WS, Kim H, Cha SB, Choi CH, Shin SJ, Kim HJ.
    Oncotarget; 2017 Mar 21; 8(12):19947-19967. PubMed ID: 28193909
    [Abstract] [Full Text] [Related]

  • 14. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 15. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F.
    Clin Exp Immunol; 2012 Sep 01; 169(3):213-9. PubMed ID: 22861360
    [Abstract] [Full Text] [Related]

  • 16. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
    Siddiqui KF, Amir M, Khan N, Rama Krishna G, Sheikh JA, Rajagopal K, Agrewala JN.
    Clin Exp Immunol; 2015 Aug 01; 181(2):286-96. PubMed ID: 25845290
    [Abstract] [Full Text] [Related]

  • 17. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
    Fukui M, Shinjo K, Umemura M, Shigeno S, Harakuni T, Arakawa T, Matsuzaki G.
    Microbiol Immunol; 2015 Dec 01; 59(12):735-43. PubMed ID: 26577130
    [Abstract] [Full Text] [Related]

  • 18. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
    Wang F, Mao L, Hou H, Wu S, Huang M, Yin B, Huang J, Zhu Q, Pan Y, Sun Z.
    Int Immunopharmacol; 2016 Mar 01; 32():39-45. PubMed ID: 26796515
    [Abstract] [Full Text] [Related]

  • 19. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S, White A, Sarfas C, Sibley L, Gleeson F, McIntyre A, Basaraba R, Clark S, Hall G, Rayner E, Williams A, Marsh PD, Dennis M.
    Tuberculosis (Edinb); 2016 Dec 01; 101():174-190. PubMed ID: 27865390
    [Abstract] [Full Text] [Related]

  • 20. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis.
    Derrick SC, Repique C, Snoy P, Yang AL, Morris S.
    Infect Immun; 2004 Mar 01; 72(3):1685-92. PubMed ID: 14977976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.